DUBLIN–( SERVICE CORD)– The “Oncolytic Infection Immunotherapy – International Strategic Service Record” has actually been included in ResearchAndMarkets.com’s offering. The worldwide market for Oncolytic Infection Immunotherapy was valued at US$ 156.8 Million in 2024 and is predicted to get to US$ 429.1 Million by 2030, expanding at a CAGR of 18.3% from 2024 to 2030. This extensive record offers an extensive evaluation of market fads, chauffeurs, and projections, assisting you make educated company choices. The record includ
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/oncolytic-virus-immunotherapy-strategic-research-business-report-2025-2030-surge-in-clinical-trials-combining-oncolytic-viruses-with-checkpoint-inhibitors-expands-therapeutic-horizons-researchandma/
